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California, Davis, Davis, CA, United States
Introduction: Multiple system atrophy (MSA) has detrimental effects on swallowing
function. The swallowing function of patients with MSA has not been systematically
characterized and the underlying pathophysiological mechanisms of dysphagia remain
poorly understood.
Objectives: To investigate the characteristics of swallow function in MSA using
high-resolution manofluorography (HRMF).
Methods: We conducted a retrospective review of twenty-five MSA patients who
underwent HRMF from 2016 to 2017. HRMF was utilized on patients with only oral diet
(Functional Oral Intake Scale (FOIS) >3). Pharyngoesophageal and proximal esophageal
pressure profiles were evaluated and compared to established normative data. The
frequency and characteristics of upper esophageal sphincter (UES) and proximal
esophageal abnormalities during rest and swallow were calculated.
Results: The ages of patient cohort in our study ranged from 48–81 years (median
65 years) with male predominance (68%). We observed a distinct abnormal deglutitive
proximal esophageal contraction (ADPEC) in 14 (56% of patients), which appears to
reflect a discoordinated response of the striated muscle esophagus. Deficient UES
relaxation duration, impaired UES relaxation, hypertensive resting UES pressure and
hypotensive resting UES pressure were detected in 8 patients (32%), 3 patients (12%),
1 patient (4%), and 11 patients (44%) respectively.
Conclusions: In patients with MSA, abnormal UES resting pressure is common. A
discoordinated proximal esophageal pressure response was identified and may be a
pathognomonic manometry finding for MSA. These findings may serve as indications of
early stage swallowing dysfunction in patients with MSA.
Keywords: multiple system atrophy, high resolution manofluorography, swallowing, upper esophageal sphincter,
proximal esophageal abnormality, pharyngoesophageal abnormality, abnormal deglutitive proximal esophageal
contraction
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INTRODUCTION
Multiple system atrophy (MSA) is a neurodegenerative disorder
that causes systemic degeneration of the cerebellar,
extrapyramidal and autonomic nervous systems in various
combinations (1) and is generally classified as parkinsonism
predominance (MSA-P) and/or cerebellar ataxia (MSA-C) (2).
Deterioration of swallowing function is one of the
manifestations of MSA that dramatically affects quality of
life and prognosis of patients (3) and dysphagia- related
complications such as respiratory infections (mostly aspiration
pneumonia) and malnutrition are most the common causes of
death (4, 5). Delayed oral and pharyngeal phases of swallowing,
in combination with impaired airway protection and esophageal
sphincter contraction disturbances, may lead to acute aspiration
and pneumonia (6). Impaired relaxation of the upper esophageal
sphincter (UES) has been reported regardless of MSA phenotype
(7). It is hypothesized that neurodegenerative changes in the
brain stem and vagus nerve might contribute to a dysfunctional
cricopharyngeous muscle, resulting in impairment of UES
opening and bolus residue in the pyriform sinuses (3, 6, 7).
Despite the prevalence of swallow dysfunction in persons with
MSA, swallowing function in MSA has not been investigated
systematically, and the underlying pathophysiological
mechanisms of dysphagia, especially the incipient swallowing
changes in MSA, remain poorly understood. Early detection of
dysphagia, prevention of aspiration pneumonia and possible
TABLE 1 | Details of severity stages of Multiple System Atrophy (10), a Functional Oral Intake Scale (11), and a Penetration Aspiration Scale (12).
Severity stages of multiple system atrophy
Stage 1 Able to walk without support
Stage 2 Aid-required walking, with use of a walking aid or a companion’s arm for support, but not at all times
Stage 3 Aid-required walking, with use, at all times, of a walking aid or a companion’s arm for support
Stage 4 Wheelchair-bound state (wheelchair use at all times)
Stage 5 Bedridden state (complete loss of ability for independent activity)
Functional oral intake scale
Level 1 No oral intake
Level 2 Tube dependent with minimal/inconsistent oral intake
Level 3 Tube supplements with consistent oral intake
Level 4 Total oral intake of a single consistency
Level 5 Total oral intake of multiple consistencies requiring special preparation
Level 6 Total oral intake with no special preparation, but must avoid specific foods or liquid items
Level 7 Total oral intake with no restrictions
Penetration-aspiration scale
Score 1 Material does not enter airway
Score 2 Material enters the airway, remains above the vocal folds, and is ejected from the airway
Score 3 Material enters the airway, remains above the vocal folds, and is not ejected from the airway
Score 4 Material enters the airway, contacts the vocal folds, and is ejected from the airway
Score 5 Material enters the airway, contacts the vocal folds, and is not ejected from the airway
Score 6 Material enters the airway, passes below the vocal folds, and is ejected into the larynx or out of the airway
Score 7 Material enters the airway, passes below the vocal folds, and is not ejected from the trachea despite effort
Score 8 Material enters the airway, passes below the vocal folds, and no effort is made to eject
intervention can increase quality of life and survival time of MSA
patients.
Technological advancements and utilizations of high-
resolution manometry (HRM) have led to a better understanding
of pharyngeal and esophageal disorders. HRM has been
utilized to characterize swallowing dysfunction in patients with
neuromuscular disease, such as Parkinson’s disease but not in
MSA. Moreover, high-resolution manofluorography (HRMF),
an armamentarium combining high-resolution manometric
and videofluoroscopic swallowing examinations, improves the
accuracy of diagnosis of esophageal disorders and facilitates
dysphagia management (8, 9). The purpose of this investigation
was to evaluate the characteristic pharyngoesophageal
and cervical esophageal findings of HRMF in patients
with MSA.
METHODS
Ethics
This study was approved by the Human Ethics Committee of
the University of Tokyo (No. 2487). Written informed consent
was obtained from every patient and patients’ anonymities were
preserved.
Patients
Twenty-five MSA patients whose diagnosis was made at the
Department of Neurology in our institute between the years
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2016 to 2017 were included. Patients’ diagnoses were confirmed
according to the Consensus Statement of diagnostic criteria and
excluded from Gilman’s criteria (2).
Methodology
We conducted a retrospective review of patients with MSA
who underwent HRMF at the University of Tokyo Hospital.
Clinical and demographic profiles were analyzed, including
age, gender, type, and severity stage of MSA (10), presence of
vocal fold immobility, Functional Oral Intake Scale (FOIS) (11),
Penetration Aspiration Scale (PAS) score (12) in thin liquid
intake (10 mPa•s) and thickened liquid intake (200 mPa•s) and
HRMF parameters.
MSA severity was designated from Stage 1 to 5 as previously
reported (10). FOIS scores (11), and PAS scores (12) were
assigned as Level 1–7 (normal level: 7) and Score 1–8 (most severe
score: 8) separately (Table 1).
High Resolution Manofluorographic Study
and Measures
HRMF studies were performed on all MSA patients who were on
an oral diet (FOIS >3) in the upright position. The manometric
catheter was lubricated with 4% viscous lidocaine and inserted
transnasally. The videofluoroscopic swallow study (VFSS) was
conducted in the lateral view simultaneously. The protocol
consisted of a 5-min baseline recording, followed by 3 dry
swallows and 3 wet swallows of 5 cc thickened contrast agent
(iohexol: Omnipaque R©, Daiichi-Sankyo, Tokyo, Japan). A solid-
state high-resolution manometer (Starlet, Star Medical, Tokyo,
Japan) was used for all data acquisition. The manometric catheter
(Unisensor, Portsmouth, NH, USA) has an outer diameter of
4mm and 20 circumferential pressure sensors spaced 1 cm apart.
The data acquisition frequency was 40Hz for each sensor. The
system is calibrated to record pressures between −50 and 300
mmHg. Video was recorded at a rate of 30 frames/s and analyzed
by Star.exeve 8.1 (Star Medical, Tokyo, Japan). Pharyngeal
and proximal esophageal measures were obtained on all
patients.
The following parameters were obtained from themanometric
output: maximum swallowing pressures (velopharynx, meso-
hypopharynx, post-deglutitive UES pressure), integrals
[velopharyngeal closure integral, meso-hypopharynx contractile
integral, post-deglutitive UES contractile integral, proximal
esophageal contractile integral during UES relaxation (early
response), proximal esophageal contractile integral], UES
relaxation duration, UES relaxation pressure (nadir) and UES
resting pressure (Figure 1).
Abnormal HRMFmetrics in the UES and proximal esophagus
were identified using the following criteria: impaired UES
relaxation pressure/duration (relaxation pressure >12
mmHg/<0.45 s), hypertensive resting UES pressure (>104
mmHg), and hypotensive resting UES pressure (<34 mmHg)
(13, 14). Proximal esophageal contraction integral above 0mmHg
during UES opening (an early response occurring concurrently
with UES opening) was also defined as abnormal, a phenomenon
observed in this study among MSA patients. The frequency of
abnormal hypertensive and discoordinated abnormal proximal
esophageal contraction during swallowing (ADPEC), deficient
UES relaxation duration, UES abnormalities, and other sub-
types of UES abnormal presentations on manometry were
calculated. Finally, subjects were divided into two groups
based on presence or absence of ADPEC and intergroup
comparison of HRMF parameters were made and correlations
between ADPEC and clinical features between groups were
evaluated.
Statistical Analysis
Statistical comparisons between groups were performed by
using Mann–Whitney U-tests implemented in GraphPad Prism
(version 6.0; GraphPad Software, Inc., La Jolla, CA, USA).
Demographic variables (type of MSA, vocal cord immobility)
were compared by Fisher’s exact test between patients with
FIGURE 1 | Measurement of UES pressure and each integral (in a healthy subject). (A) Resting UES pressure, (B) VCI, Velopharyngeal closure integral, (C) MHCI,
Meso-hypopharynx contractile integral, (D) PDUCI, Post-deglutitive UES contractile integral, (E) PECIDS, Proximal esophageal contractile integral during swallowing,
(F) PPECI, Post-deglutitive proximal esophageal contractile integral.
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or without ADPEC. P < 0.05 was considered statistically
significant.
RESULTS
Demographic Data
Data from the charts of 25 patients with MSA were abstracted.
The age of the cohort (Table 2) ranged from 48 to 81 years
(median 65 years). Sixty-eight percent (17/25) was male. Seven
out of 25 patients were diagnosed with MSA-P (Parkinsonian
features predominant type MSA), and the remaining 18 patients
were diagnosed with MSA-C (cerebellar symptoms predominant
type MSA). Regarding MSA severity, 7 patients were stage 1 or 2,
10 patients were stage 3 and 8 patients were designated stage 4.
Bilateral vocal fold immobility was detected in 8 patients (32%).
Total oral nutritional dependence was noted in all patients.13
patients (52%) had no restrictions (FOIS 7), 8 patients (32%) had
minimal dietary restrictions (FOIS 6), and 4 patients (16%) had
moderate diet modification (FOIS 5). For thin liquids, 15 patients
(60%) had PAS 1-3, 5 patients (20%) had a PAS of 4-6, and 5
patients (20%) had a PAS of 7 or 8. For thickened liquids, 20
patients (80%) had a normal PAS (PAS 1), 3 patients (12%) had a
PAS of 2, and 2 patients (8%) had a PAS of 6.
HRMF Pharyngeal and Proximal
Esophageal Metrics in MSA Patients
Mean, standard deviation and the measured ranges for each
pharyngeal and proximal esophageal metric from patients with
MSA included in this study are shown in Table 3. The maximum
swallowing pressures and integrals of each segment, UES
relaxation duration, resting UES pressure and UES relaxation
pressure (nadir) were included. Pharyngeal contraction and UES
status were verified for each study by VFSS in order to minimize
measurement errors.
Abnormal HRMF Findings of UES and
Proximal Esophageal Metrics
HRMF measurements of UES and proximal esophageal metrics
on pressure topography are illustrated in Figure 1. HRMF
revealed a pattern of abnormal hypertensive and discoordinated
TABLE 2 | Demographic data and high-resolution manofluorography (HRMF) findings of upper esophageal sphincter (UES) and proximal esophageal metrics in multiple
system atrophy (MSA) patients.
No. Age Sex Type Severity
stage
Vocal cord
immobility
FOIS PAS APECDS UES opening UES relaxation Resting UES
pressure
Liquid Thickened
1 65 M MSA-C 2 No 7 1 1 + Normal Normal Hypotensive
2 62 M MSA-C 1 No 7 1 1 + Deficient Normal Normal
3 57 M MSA-C 3 No 7 1 1 − Normal Normal Normal
4 53 M MSA-C 2 No 7 1 1 − Normal Impaired Normal
5 55 M MSA-C 2 No 7 1 1 − Normal Normal Normal
6 53 M MSA-C 3 No 7 1 1 + Normal Normal Normal
7 47 F MSA-C 3 Bilateral 7 1 1 + Normal Normal Hypotensive
8 77 M MSA-C 3 No 7 1 1 + Normal Normal Normal
9 70 M MSA-P 2 Bilateral 7 1 1 − Normal Normal Normal
10 67 M MSA-P 2 No 7 1 1 + Deficient Normal Hypotensive
11 64 M MSA-P 3 No 7 1 1 − Normal Normal Hypotensive
12 66 M MSA-P 3 No 7 1 1 + Normal Normal Hypotensive
13 65 F MSA-P 4 Bilateral 7 1 1 + Deficient Normal Hypotensive
14 70 F MSA-C 4 Bilateral 6 2 1 − Normal Normal Hypotensive
15 68 M MSA-C 3 Bilateral 6 2 1 + Normal Normal Hypotensive
16 64 M MSA-C 2 No 6 4 1 + Normal Normal Normal
17 79 F MSA-P 3 No 6 4 1 + Normal Normal Normal
18 70 F MSA-C 4 Bilateral 6 6 1 − Normal Normal Normal
19 68 M MSA-C 4 Bilateral 5 6 2 + Deficient Normal Hypotensive
20 56 F MSA-C 4 No 5 6 2 + Deficient Normal Normal
21 81 F MSA-P 3 Bilateral 6 7 1 − Normal Normal Normal
22 55 M MSA-C 4 No 5 7 6 − Normal Normal Normal
23 60 F MSA-C 4 No 6 8 1 − Deficient Normal Hypotensive
24 68 M MSA-C 4 No 6 8 2 − Deficient Impaired Hypotensive
25 56 M MSA-C 3 No 5 8 6 + Deficient Impaired Hypertensive
MSA-P, Parkinsonian features predominant type MSA; MSA-C, Cerebellar symptoms predominant type MSA; FOIS, Functional Oral Intake Scale; PAS, Penetration Aspiration Scale;
ADPEC, Abnorma deglutitive proximal esophageal contraction.
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proximal esophageal contraction during swallowing (ADPEC)
(Figure 2) in 14 patients (56%). Deficient UES relaxation
duration, impaired UES relaxation, hypertensive resting UES
pressure and hypotensive resting UES pressure were detected in
TABLE 3 | Statistical summary of HRMF from patients with MSA.
Mean ± SD (5–95th percentile)
Maximum pressure (mmHg)
Velopharynx 222 ± 70 (193–251)
Meso-hypopharynx 324 ± 115 (277–372)
Post-deglutitive UES 417 ± 115 (369–464)
Integral (mmHg/s/cm)
VCI 121 ± 60 (97–146)
MHCI 300 ± 118 (251–348)
PDUCI 636 ± 402 (470–802)
PECIDS 53 ± 77 (21–85)
PPECI 83 ± 105 (40–127)
Resting UES pressure (mmHg) 44 ± 35 (30–59)
UES opening duration (ms) 473 ± 112 (427–519)
UES relaxation pressure-nadir (mmHg) −0.8 ± 18.2 (−8.3–6.7)
Values are mean ± SD (5–95th percentile). UES, Upper esophageal sphincter; VCI,
Velopharyngeal closure integral; MHCI, Meso-hypopharynx contractile integral; PDUCI,
Post-deglutitive UES contractile integral; PECIDS, Proximal esophageal contractile integral
during swallowing; PPECI, Post-deglutitive proximal esophageal contractile integral.
8 patients (32%), 3 patients (12%), 1 patient (4%), and 11 patients
(44%), respectively.
Comparison of Clinical Features and HRMF
Values Between Groups With and Without
Abnormal Hypertensive and
Discoordinated Proximal Esophageal
Contraction During Swallowing
There were no statistically significant differences in any of the
HRMF values between groups with or without ADPEC. Similarly,
no significant associations were found between the presence of
ADPEC and types of MSA (OR 0.94; 95% CI 0.16–5.46; p= 1.00)
or presence of vocal fold immobility (OR 0.70; 95% CI 0.13–3.79;
p= 0.69). There was no significant difference in severity stages of
MSA between groups with and without ADPEC (Table 4).
DISCUSSION
Swallowing dysfunction is common in patients with MSA.
Appropriate evaluations for dysphagia may prevent or delay
complications such as aspiration pneumonia and sudden death.
In this study, abnormal UES pressures and a pattern of
discoordinated proximal esophageal contraction pressure during
swallowing and resting were identified in MSA patients with
oral nutritional status (FOIS score >3). These findings did not
FIGURE 2 | (A) Representative pattern of abnormal hypertensive and discoordinated proximal esophageal contraction during swallowing (ADPEC: The area
surrounded by a white broken line). A black broken line shows the view point of the static fluoroscopic image. (B) 1.0 s time series images of fluoroscopic examination.
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TABLE 4 | Comparison of HRMF values between groups with/without abnormal discoordinated deglutitive proximal esophageal contraction (ADPEC) and associations of
ADPEC and type of MSA, vocal cord immobility.
Non-ADPEC ADPEC P-value
Maximum pressure (mmHg)
Velopharynx 201 ± 68 (156–247) 230 ± 70 (190–271) 0.62
Meso-hypopharynx 334 ± 127 (249–420) 327 ± 122 (257–398) 0.78
Post-deglutitive UES 407 ± 97 (342–472) 434 ± 136 (355–514) 0.9
Integral (mmHg/s/cm)
VCI 117 ± 51 (82–151) 122 ± 65 (85–160) 0.78
MHCI 290 ± 146 (192–379) 299 ± 77 (255–344) 0.66
PDUCI 631 ± 530 (275–986) 614 ± 313 (433–795) 0.7
PPECI 99 ± 145 (14–196) 72 ± 62 (36–108) 0.68
Resting UES pressure (mmHg) 37 ± 2 (21–53) 50 ± 41 (26–74) 0.74
UES opening duration (ms) 510 ± 86 (453–568) 443 ± 124 (372–515) 0.14
UES relaxation pressure-nadir (mmHg) −1.8 ± 12.1 (-9.9–6.2) −0.0 ± 22.2 (−12.9–12.8) 0.66
MSA-C/MSA-P 8/3 10/4 1.00
VCIm/Non-VCIm 4/7 4/10 0.69
Severity stage 2.9 ± 0.86 3.2 ± 0.87 0.38
Values are mean ± SD (5–95th percentile). UES, Upper esophageal sphincter; VCI, Velopharyngeal closure integral; MHCI, Meso-hypopharynx contractile integral; PDUCI, Post-
deglutitive UES contractile integral; PECIDS, Proximal esophageal contractile integral during swallowing; PPECI, Post-deglutitive proximal esophageal contractile integral; MSA-P,
Parkinsonian features predominant type MSA; MSA-C, Cerebellar symptoms predominant type MSA; VCIm, vocal cord immobility.
correlate with the severity stage, types of MSA, or concurrent
vocal fold immobility.
MSA is a progressive neurodegenerative disease and can
affect swallowing function variably with disease progression.
The disordered oral stage of swallowing manifests in delayed
bolus transport to the pharynx and worsens progressively
due to bradykinesia and disrupted tongue coordination (15).
Diminished oropharyngeal and hypopharyngeal manometric
swallowing pressures of various degrees have been reported (7).
The current investigation supports these data and suggests that
pharyngeal pressures on HRMF are variable. In addition, another
study showed 23.1% of MSA patients had incomplete relaxation
of the UES (7). Deficient UES relaxation duration and impaired
UES relaxation were also found in certain MSA patients in this
study, however, the pathophysiology of how MSA affected the
UES remains incompletely understood.
MSA can also cause esophageal stage impairments such
as dysmotility (16). It has been proposed that preganglionic
cholinergic dysfunction and specifically loss of the dorsal vagal
nucleus innervating the digestive system lead to food stagnation
within the esophagus (17) and occur more prevalently in MSA
patients with dysphagia (16). Thus, evaluation of the esophageal
phase is also indicated.
Complex sequences of swallowing are controlled and
regulated by the medullary swallowing center, which is also
known as the central pattern generators (CPGs) (18). The
finding of ADPEC in MSA patients in this study may be an
example of abnormal or discoordinated motility stemming from
central nervous system dysfunction. Additional investigations are
necessary to obtain a better understanding of the mechanism
of ADPEC in patients with MSA and other neurodegenerative
disease.
Vocal fold immobility is another frequent complication of
MSA (3). Swallowing dysfunction and vocal fold immobility
are related, as both the thyropharyngeal and cricopharyngeal
muscles are innervated by the vagus nerve (3, 7). Few studies
have evaluated the relationship between vocal fold immobility
and dysphagia in MSA. We previously reported that vocal
fold abductor paralysis tended to precede dysphagia in MSA-
C patients (19) and the MSA-C patients with severe vocal
fold abductor paralysis also suffered from severe dysphagia
(3). Impaired UES opening and bolus stasis at the pyriform
sinuses have been reported as associated with vocal fold
abductor paralysis in MSA (7). In this study, however,
no significant association was found between ADPEC and
vocal fold immobility. This could result from the restriction
of patients with only mild or moderate severity MSA in
our cohort. An association between ADPEC and vocal fold
immobility may be more common in patients with high
severity MSA.
HRMF can improve understanding and advance our
capabilities of evaluating the pharyngo-esophageal region.
In this study, concurrent UES and proximal esophageal
abnormalities, possibly due to neuromuscular dysfunction,
were frequently noted even in mild MSA patients, and
ADPEC identified on HRMF may be suggestive of MSA.
Our findings suggest that HRMF may assist with the earlier
detection of deglutitive abnormalities before the symptom
of dysphagia develops. However, it is not fully clear whether
the ADPEC is an early indication of pathophysiologic and
neurodegenerative changes in MSA patients, an indicator
of MSA severity, or possibly a compensatory proximal
esophageal contraction in response to ongoing pharyngo-
esophageal dysmotility. Longitudinal observations are required
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to elucidate the clinical significance of ADPEC in patients with
MSA.
MSA affects the autonomic nervous system and
swallowing function progressively. Pulmonary complications,
malnourishments, or even mortality is related to clinical
deterioration. The data suggest that HRMF may be beneficial for
the early detection of swallowing dysfunction in MSA patients.
Further investigation is required to confirm the accuracy of
HRMF in the early detection of MSA and assess the effect of early
detection on wellness and quality of life.
CONCLUSIONS
UES pressure anomalies and a discoordinated proximal
esophageal pressure response are common manometric findings
in persons with MSA. Further investigation is required to
investigate the mechanisms underlying this pressure pattern and
validate the application of HRMF as a diagnostic tool for MSA.
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